Cardiol Therapeutics Inc. buy krebskrebs
Start price
15.11.21
/
50%
€2.16
Target price
15.11.22
€4.00
Performance (%)
-72.50%
End price
16.11.22
€0.59
Summary
This prediction ended on 16.11.22 with a price of €0.59. Massive losses of -72.50% were the result for the BUY prediction by krebskrebs. krebskrebs has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Cardiol Therapeutics Inc. | - | - | - |
iShares Core DAX® | 2.749% | 4.620% | 17.121% |
iShares Nasdaq 100 | 0.470% | -0.331% | 37.776% |
iShares Nikkei 225® | -2.930% | -5.556% | 12.185% |
iShares S&P 500 | 0.679% | 0.631% | 28.996% |
Comments by krebskrebs for this prediction
In the thread Cardiol Therapeutics Inc. diskutieren
Buy mit Kursziel 4,0
In the thread Trading Cardiol Therapeutics Inc.
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten